coumarin has been researched along with Body Weight in 12 studies
2H-chromen-2-one: coumarin derivative
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 8.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "The purpose of the investigation was to prepare a new type of nanoparticle, namely lapatinib-incorporated lipoprotein-like nanoparticles (LTNPs), and to evaluate the behavior and anti-glioma effect of LTNPs." | 7.78 | Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles. ( Cao, S; Gao, H; Jiang, X; Pang, Z; Xi, Z; Yang, Z; Zhang, S, 2012) |
| " The efficacy of coumarin (1,2-benzopyrone) was examined for the regulation of hyperthyroidism in female rats." | 7.74 | Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats. ( Kar, A; Panda, S, 2007) |
| "The histogenesis of coumarin-induced cholangiofibrosis in the rat has been determined." | 7.67 | Studies on the induction of cholangiofibrosis by coumarin in the rat. ( Appleby, EC; Conning, DM; Evans, JG; Lake, BG, 1989) |
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 4.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "The purpose of the investigation was to prepare a new type of nanoparticle, namely lapatinib-incorporated lipoprotein-like nanoparticles (LTNPs), and to evaluate the behavior and anti-glioma effect of LTNPs." | 3.78 | Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles. ( Cao, S; Gao, H; Jiang, X; Pang, Z; Xi, Z; Yang, Z; Zhang, S, 2012) |
| " The efficacy of coumarin (1,2-benzopyrone) was examined for the regulation of hyperthyroidism in female rats." | 3.74 | Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats. ( Kar, A; Panda, S, 2007) |
| "A randomized sampling protocol coupled with quantitative morphometry has been used to evaluate the inter-lobe variation in centrilobular hepatic necrosis in the mouse, and periportal hepatic necrosis in the beta-naphthoflavone-induced rat, both in response to treatment with coumarin." | 3.69 | Further studies on the lobar heterogeneity in response to coumarin-mediated hepatotoxicity. ( Fry, JR; Jack, KR; Kho, K; Thomas, NW, 1996) |
| "The histogenesis of coumarin-induced cholangiofibrosis in the rat has been determined." | 3.67 | Studies on the induction of cholangiofibrosis by coumarin in the rat. ( Appleby, EC; Conning, DM; Evans, JG; Lake, BG, 1989) |
| " The aim of this work was to evaluate antidiabetic activity in Streptozotocin (STZ)-induced diabetic rats and the antioxidant effects of 3',4'-Di-O-acetyl-cis-khellactone (DOAcK), as well as its toxic potential." | 1.43 | Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats. ( Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C, 2016) |
| "Coumarin is a natural compound abundant in plant-based foods such as citrus fruits, tomatoes, vegetables and green tea." | 1.39 | Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet. ( Ahn, J; Moon, MK; Um, MY; Youl Ha, T, 2013) |
| "The pharmacokinetic parameters, total body clearance, apparent volume of distribution and the terminal elimination half-life of coumarin were correlated among six mammalian species." | 1.28 | Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species. ( Hussain, AS; Johnson, RD; Ritschel, WA; Vachharajani, NN, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Domínguez-Mendoza, EA | 1 |
| Cornejo-Garrido, J | 1 |
| Burgueño-Tapia, E | 1 |
| Ordaz-Pichardo, C | 1 |
| Ghazouani, L | 1 |
| Khdhiri, E | 1 |
| Elmufti, A | 1 |
| Zarei, A | 1 |
| Feriani, A | 1 |
| Baaziz, I | 1 |
| Hajji, R | 1 |
| Abid, M | 1 |
| Ammar, H | 1 |
| Abid, S | 1 |
| Allouche, N | 1 |
| Mnafgui, K | 1 |
| Ramazani, A | 1 |
| Tlili, N | 1 |
| Um, MY | 1 |
| Moon, MK | 1 |
| Ahn, J | 1 |
| Youl Ha, T | 1 |
| Gao, H | 1 |
| Yang, Z | 1 |
| Cao, S | 1 |
| Xi, Z | 1 |
| Zhang, S | 1 |
| Pang, Z | 1 |
| Jiang, X | 1 |
| Panda, S | 1 |
| Kar, A | 1 |
| Brattsten, LB | 1 |
| Evans, CK | 1 |
| Bonetti, S | 1 |
| Zalkow, LH | 1 |
| Russo, P | 1 |
| Warner, JA | 1 |
| Huryk, R | 1 |
| Perez, G | 1 |
| Heston, WD | 1 |
| Jack, KR | 1 |
| Kho, K | 1 |
| Thomas, NW | 1 |
| Fry, JR | 1 |
| Carlton, BD | 1 |
| Aubrun, JC | 1 |
| Simon, GS | 1 |
| Lake, BG | 2 |
| Grasso, P | 1 |
| Ritschel, WA | 1 |
| Vachharajani, NN | 1 |
| Johnson, RD | 1 |
| Hussain, AS | 1 |
| Evans, JG | 1 |
| Appleby, EC | 1 |
| Conning, DM | 1 |
12 other studies available for coumarin and Body Weight
| Article | Year |
|---|---|
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Coumarins; Diabetes Mellitus, Experimen | 2016 |
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes
Topics: Animals; Antioxidants; Body Weight; Cardiotonic Agents; Catalase; Coumarins; Electrocardiography; Gl | 2022 |
Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet.
Topics: Adiposity; Animals; Base Sequence; Blotting, Western; Body Weight; Coumarins; Dietary Fats; DNA Prim | 2013 |
Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Coumarins; Endocytosis; Fluorescent A | 2012 |
Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats.
Topics: Animals; Antithyroid Agents; Body Weight; Catalase; Cholesterol; Coumarins; Disease Models, Animal; | 2007 |
Induction by carrot allelochemicals of insecticide-metabolising enzymes in the southern armyworm (Spodoptera eridania).
Topics: Animals; Body Weight; Coumarins; Cytochrome P-450 Enzyme System; Enzyme Induction; Ergosterol; Gluta | 1984 |
TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
Topics: Animals; Apoptosis; Body Weight; Clusterin; Coumarins; Diethylstilbestrol; Finasteride; Flutamide; G | 1994 |
Further studies on the lobar heterogeneity in response to coumarin-mediated hepatotoxicity.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Body Weight; Coumarins; Liver; Male; Mice; Necrosis; Or | 1996 |
Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice.
Topics: Animal Feed; Animals; Animals, Newborn; Body Weight; Carcinogenicity Tests; Coumarins; Drug Administ | 1996 |
Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study.
Topics: Alanine Transaminase; Animals; Bilirubin; Body Weight; Coumarins; Cricetinae; DNA Replication; Dose- | 1996 |
Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species.
Topics: Animals; Body Weight; Coumarins; Dogs; Half-Life; Haplorhini; Humans; Liver; Liver Circulation; Meta | 1991 |
Studies on the induction of cholangiofibrosis by coumarin in the rat.
Topics: Animals; Atrophy; Bile Ducts, Intrahepatic; Body Weight; Coumarins; Fibrosis; gamma-Glutamyltransfer | 1989 |